nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—Carboplatin—testicular cancer	0.399	0.539	CbGbCtD
Cefaclor—MPO—Cisplatin—testicular cancer	0.341	0.461	CbGbCtD
Cefaclor—Influenza—Doxorubicin—testicular cancer	0.000269	0.00104	CcSEcCtD
Cefaclor—Asthma—Doxorubicin—testicular cancer	0.000269	0.00104	CcSEcCtD
Cefaclor—Asthenia—Ifosfamide—testicular cancer	0.000268	0.00103	CcSEcCtD
Cefaclor—Eosinophilia—Doxorubicin—testicular cancer	0.000266	0.00103	CcSEcCtD
Cefaclor—Sweating—Methotrexate—testicular cancer	0.000266	0.00102	CcSEcCtD
Cefaclor—Feeling abnormal—Cisplatin—testicular cancer	0.000265	0.00102	CcSEcCtD
Cefaclor—Paraesthesia—Etoposide—testicular cancer	0.000265	0.00102	CcSEcCtD
Cefaclor—Pruritus—Ifosfamide—testicular cancer	0.000264	0.00102	CcSEcCtD
Cefaclor—Haematuria—Methotrexate—testicular cancer	0.000264	0.00102	CcSEcCtD
Cefaclor—Dyspnoea—Etoposide—testicular cancer	0.000263	0.00101	CcSEcCtD
Cefaclor—Somnolence—Etoposide—testicular cancer	0.000262	0.00101	CcSEcCtD
Cefaclor—Hepatobiliary disease—Methotrexate—testicular cancer	0.000262	0.00101	CcSEcCtD
Cefaclor—Epistaxis—Methotrexate—testicular cancer	0.000261	0.00101	CcSEcCtD
Cefaclor—Nausea—Bleomycin—testicular cancer	0.00026	0.001	CcSEcCtD
Cefaclor—Infestation NOS—Epirubicin—testicular cancer	0.000259	0.000999	CcSEcCtD
Cefaclor—Infestation—Epirubicin—testicular cancer	0.000259	0.000999	CcSEcCtD
Cefaclor—Vomiting—Dactinomycin—testicular cancer	0.000259	0.000999	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—testicular cancer	0.000259	0.000997	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000257	0.000991	CcSEcCtD
Cefaclor—Rash—Dactinomycin—testicular cancer	0.000257	0.000991	CcSEcCtD
Cefaclor—Decreased appetite—Etoposide—testicular cancer	0.000256	0.000988	CcSEcCtD
Cefaclor—Diarrhoea—Ifosfamide—testicular cancer	0.000256	0.000985	CcSEcCtD
Cefaclor—Pancytopenia—Doxorubicin—testicular cancer	0.000255	0.000985	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Etoposide—testicular cancer	0.000255	0.000982	CcSEcCtD
Cefaclor—Body temperature increased—Cisplatin—testicular cancer	0.000255	0.000981	CcSEcCtD
Cefaclor—Constipation—Etoposide—testicular cancer	0.000252	0.000972	CcSEcCtD
Cefaclor—Pain—Etoposide—testicular cancer	0.000252	0.000972	CcSEcCtD
Cefaclor—Conjunctivitis—Epirubicin—testicular cancer	0.000252	0.000971	CcSEcCtD
Cefaclor—Neutropenia—Doxorubicin—testicular cancer	0.000252	0.00097	CcSEcCtD
Cefaclor—Dysuria—Doxorubicin—testicular cancer	0.000252	0.00097	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—testicular cancer	0.00025	0.000964	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—testicular cancer	0.000249	0.000959	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—testicular cancer	0.000249	0.000959	CcSEcCtD
Cefaclor—Sweating—Epirubicin—testicular cancer	0.000249	0.000958	CcSEcCtD
Cefaclor—Haematuria—Epirubicin—testicular cancer	0.000247	0.000953	CcSEcCtD
Cefaclor—Dizziness—Ifosfamide—testicular cancer	0.000247	0.000952	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—testicular cancer	0.000246	0.000947	CcSEcCtD
Cefaclor—Hepatobiliary disease—Epirubicin—testicular cancer	0.000245	0.000945	CcSEcCtD
Cefaclor—Epistaxis—Epirubicin—testicular cancer	0.000245	0.000943	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—testicular cancer	0.000244	0.00094	CcSEcCtD
Cefaclor—Sinusitis—Epirubicin—testicular cancer	0.000243	0.000938	CcSEcCtD
Cefaclor—Feeling abnormal—Etoposide—testicular cancer	0.000243	0.000937	CcSEcCtD
Cefaclor—Nausea—Dactinomycin—testicular cancer	0.000242	0.000933	CcSEcCtD
Cefaclor—Agranulocytosis—Epirubicin—testicular cancer	0.000242	0.000933	CcSEcCtD
Cefaclor—Gastrointestinal pain—Etoposide—testicular cancer	0.000241	0.00093	CcSEcCtD
Cefaclor—Infestation NOS—Doxorubicin—testicular cancer	0.00024	0.000925	CcSEcCtD
Cefaclor—Infestation—Doxorubicin—testicular cancer	0.00024	0.000925	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000238	0.000917	CcSEcCtD
Cefaclor—Vomiting—Ifosfamide—testicular cancer	0.000237	0.000915	CcSEcCtD
Cefaclor—Hypersensitivity—Cisplatin—testicular cancer	0.000237	0.000914	CcSEcCtD
Cefaclor—Rash—Ifosfamide—testicular cancer	0.000235	0.000908	CcSEcCtD
Cefaclor—Dermatitis—Ifosfamide—testicular cancer	0.000235	0.000907	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—testicular cancer	0.000235	0.000906	CcSEcCtD
Cefaclor—Urticaria—Etoposide—testicular cancer	0.000234	0.000903	CcSEcCtD
Cefaclor—Haemoglobin—Epirubicin—testicular cancer	0.000234	0.000902	CcSEcCtD
Cefaclor—Rhinitis—Epirubicin—testicular cancer	0.000233	0.000899	CcSEcCtD
Cefaclor—Body temperature increased—Etoposide—testicular cancer	0.000233	0.000899	CcSEcCtD
Cefaclor—Abdominal pain—Etoposide—testicular cancer	0.000233	0.000899	CcSEcCtD
Cefaclor—Conjunctivitis—Doxorubicin—testicular cancer	0.000233	0.000899	CcSEcCtD
Cefaclor—Hepatitis—Epirubicin—testicular cancer	0.000233	0.000897	CcSEcCtD
Cefaclor—Haemorrhage—Epirubicin—testicular cancer	0.000233	0.000897	CcSEcCtD
Cefaclor—Asthenia—Cisplatin—testicular cancer	0.000231	0.00089	CcSEcCtD
Cefaclor—Sweating—Doxorubicin—testicular cancer	0.00023	0.000886	CcSEcCtD
Cefaclor—Urinary tract disorder—Epirubicin—testicular cancer	0.00023	0.000886	CcSEcCtD
Cefaclor—Oedema peripheral—Epirubicin—testicular cancer	0.000229	0.000884	CcSEcCtD
Cefaclor—Haematuria—Doxorubicin—testicular cancer	0.000229	0.000882	CcSEcCtD
Cefaclor—Urethral disorder—Epirubicin—testicular cancer	0.000228	0.000879	CcSEcCtD
Cefaclor—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000227	0.000875	CcSEcCtD
Cefaclor—Epistaxis—Doxorubicin—testicular cancer	0.000226	0.000872	CcSEcCtD
Cefaclor—Sinusitis—Doxorubicin—testicular cancer	0.000225	0.000868	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—testicular cancer	0.000225	0.000866	CcSEcCtD
Cefaclor—Agranulocytosis—Doxorubicin—testicular cancer	0.000224	0.000863	CcSEcCtD
Cefaclor—Chills—Methotrexate—testicular cancer	0.000223	0.00086	CcSEcCtD
Cefaclor—Nausea—Ifosfamide—testicular cancer	0.000222	0.000855	CcSEcCtD
Cefaclor—Diarrhoea—Cisplatin—testicular cancer	0.00022	0.000849	CcSEcCtD
Cefaclor—Erythema multiforme—Epirubicin—testicular cancer	0.00022	0.000848	CcSEcCtD
Cefaclor—Hypersensitivity—Etoposide—testicular cancer	0.000217	0.000838	CcSEcCtD
Cefaclor—Haemoglobin—Doxorubicin—testicular cancer	0.000216	0.000834	CcSEcCtD
Cefaclor—Rhinitis—Doxorubicin—testicular cancer	0.000216	0.000832	CcSEcCtD
Cefaclor—Haemorrhage—Doxorubicin—testicular cancer	0.000215	0.00083	CcSEcCtD
Cefaclor—Hepatitis—Doxorubicin—testicular cancer	0.000215	0.00083	CcSEcCtD
Cefaclor—Urinary tract disorder—Doxorubicin—testicular cancer	0.000213	0.00082	CcSEcCtD
Cefaclor—Oedema peripheral—Doxorubicin—testicular cancer	0.000212	0.000818	CcSEcCtD
Cefaclor—Asthenia—Etoposide—testicular cancer	0.000212	0.000816	CcSEcCtD
Cefaclor—Urethral disorder—Doxorubicin—testicular cancer	0.000211	0.000814	CcSEcCtD
Cefaclor—Immune system disorder—Epirubicin—testicular cancer	0.00021	0.00081	CcSEcCtD
Cefaclor—Back pain—Methotrexate—testicular cancer	0.000209	0.000807	CcSEcCtD
Cefaclor—Chills—Epirubicin—testicular cancer	0.000209	0.000805	CcSEcCtD
Cefaclor—Pruritus—Etoposide—testicular cancer	0.000209	0.000804	CcSEcCtD
Cefaclor—Vomiting—Cisplatin—testicular cancer	0.000205	0.000789	CcSEcCtD
Cefaclor—Erythema multiforme—Doxorubicin—testicular cancer	0.000204	0.000785	CcSEcCtD
Cefaclor—Rash—Cisplatin—testicular cancer	0.000203	0.000783	CcSEcCtD
Cefaclor—Dermatitis—Cisplatin—testicular cancer	0.000203	0.000782	CcSEcCtD
Cefaclor—Diarrhoea—Etoposide—testicular cancer	0.000202	0.000778	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—testicular cancer	0.000201	0.000774	CcSEcCtD
Cefaclor—Flatulence—Epirubicin—testicular cancer	0.0002	0.00077	CcSEcCtD
Cefaclor—Tension—Epirubicin—testicular cancer	0.000199	0.000766	CcSEcCtD
Cefaclor—Nervousness—Epirubicin—testicular cancer	0.000197	0.000759	CcSEcCtD
Cefaclor—Back pain—Epirubicin—testicular cancer	0.000196	0.000755	CcSEcCtD
Cefaclor—Malaise—Methotrexate—testicular cancer	0.000195	0.000753	CcSEcCtD
Cefaclor—Dizziness—Etoposide—testicular cancer	0.000195	0.000752	CcSEcCtD
Cefaclor—Immune system disorder—Doxorubicin—testicular cancer	0.000194	0.00075	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—testicular cancer	0.000194	0.00075	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—testicular cancer	0.000194	0.000747	CcSEcCtD
Cefaclor—Chills—Doxorubicin—testicular cancer	0.000193	0.000745	CcSEcCtD
Cefaclor—Nausea—Cisplatin—testicular cancer	0.000191	0.000737	CcSEcCtD
Cefaclor—Cough—Methotrexate—testicular cancer	0.000189	0.000728	CcSEcCtD
Cefaclor—Ill-defined disorder—Epirubicin—testicular cancer	0.000188	0.000725	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—testicular cancer	0.000188	0.000723	CcSEcCtD
Cefaclor—Vomiting—Etoposide—testicular cancer	0.000188	0.000723	CcSEcCtD
Cefaclor—Agitation—Epirubicin—testicular cancer	0.000186	0.000718	CcSEcCtD
Cefaclor—Rash—Etoposide—testicular cancer	0.000186	0.000717	CcSEcCtD
Cefaclor—Dermatitis—Etoposide—testicular cancer	0.000186	0.000716	CcSEcCtD
Cefaclor—Headache—Etoposide—testicular cancer	0.000185	0.000712	CcSEcCtD
Cefaclor—Flatulence—Doxorubicin—testicular cancer	0.000185	0.000712	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—testicular cancer	0.000184	0.00071	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—testicular cancer	0.000184	0.00071	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—testicular cancer	0.000184	0.00071	CcSEcCtD
Cefaclor—Tension—Doxorubicin—testicular cancer	0.000184	0.000709	CcSEcCtD
Cefaclor—Malaise—Epirubicin—testicular cancer	0.000183	0.000704	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—testicular cancer	0.000182	0.000702	CcSEcCtD
Cefaclor—Nervousness—Doxorubicin—testicular cancer	0.000182	0.000702	CcSEcCtD
Cefaclor—Vertigo—Epirubicin—testicular cancer	0.000182	0.000702	CcSEcCtD
Cefaclor—Syncope—Epirubicin—testicular cancer	0.000182	0.0007	CcSEcCtD
Cefaclor—Leukopenia—Epirubicin—testicular cancer	0.000181	0.000699	CcSEcCtD
Cefaclor—Back pain—Doxorubicin—testicular cancer	0.000181	0.000699	CcSEcCtD
Cefaclor—Palpitations—Epirubicin—testicular cancer	0.000179	0.00069	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—testicular cancer	0.000178	0.000687	CcSEcCtD
Cefaclor—Loss of consciousness—Epirubicin—testicular cancer	0.000178	0.000686	CcSEcCtD
Cefaclor—Cough—Epirubicin—testicular cancer	0.000177	0.000681	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—testicular cancer	0.000177	0.000681	CcSEcCtD
Cefaclor—Convulsion—Epirubicin—testicular cancer	0.000176	0.000677	CcSEcCtD
Cefaclor—Nausea—Etoposide—testicular cancer	0.000175	0.000675	CcSEcCtD
Cefaclor—Ill-defined disorder—Doxorubicin—testicular cancer	0.000174	0.00067	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—testicular cancer	0.000173	0.000668	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—testicular cancer	0.000173	0.000667	CcSEcCtD
Cefaclor—Myalgia—Epirubicin—testicular cancer	0.000172	0.000665	CcSEcCtD
Cefaclor—Chest pain—Epirubicin—testicular cancer	0.000172	0.000665	CcSEcCtD
Cefaclor—Arthralgia—Epirubicin—testicular cancer	0.000172	0.000665	CcSEcCtD
Cefaclor—Agitation—Doxorubicin—testicular cancer	0.000172	0.000664	CcSEcCtD
Cefaclor—Anxiety—Epirubicin—testicular cancer	0.000172	0.000663	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—testicular cancer	0.000171	0.000658	CcSEcCtD
Cefaclor—Discomfort—Epirubicin—testicular cancer	0.00017	0.000657	CcSEcCtD
Cefaclor—Malaise—Doxorubicin—testicular cancer	0.000169	0.000652	CcSEcCtD
Cefaclor—Vertigo—Doxorubicin—testicular cancer	0.000168	0.000649	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—testicular cancer	0.000168	0.000649	CcSEcCtD
Cefaclor—Syncope—Doxorubicin—testicular cancer	0.000168	0.000648	CcSEcCtD
Cefaclor—Leukopenia—Doxorubicin—testicular cancer	0.000168	0.000647	CcSEcCtD
Cefaclor—Confusional state—Epirubicin—testicular cancer	0.000167	0.000643	CcSEcCtD
Cefaclor—Palpitations—Doxorubicin—testicular cancer	0.000166	0.000639	CcSEcCtD
Cefaclor—Anaphylactic shock—Epirubicin—testicular cancer	0.000165	0.000637	CcSEcCtD
Cefaclor—Oedema—Epirubicin—testicular cancer	0.000165	0.000637	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—testicular cancer	0.000165	0.000636	CcSEcCtD
Cefaclor—Loss of consciousness—Doxorubicin—testicular cancer	0.000165	0.000635	CcSEcCtD
Cefaclor—Cough—Doxorubicin—testicular cancer	0.000164	0.000631	CcSEcCtD
Cefaclor—Shock—Epirubicin—testicular cancer	0.000163	0.000627	CcSEcCtD
Cefaclor—Convulsion—Doxorubicin—testicular cancer	0.000162	0.000626	CcSEcCtD
Cefaclor—Nervous system disorder—Epirubicin—testicular cancer	0.000162	0.000625	CcSEcCtD
Cefaclor—Thrombocytopenia—Epirubicin—testicular cancer	0.000162	0.000624	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000161	0.000621	CcSEcCtD
Cefaclor—Hyperhidrosis—Epirubicin—testicular cancer	0.00016	0.000616	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—testicular cancer	0.00016	0.000616	CcSEcCtD
Cefaclor—Chest pain—Doxorubicin—testicular cancer	0.00016	0.000615	CcSEcCtD
Cefaclor—Arthralgia—Doxorubicin—testicular cancer	0.00016	0.000615	CcSEcCtD
Cefaclor—Myalgia—Doxorubicin—testicular cancer	0.00016	0.000615	CcSEcCtD
Cefaclor—Anxiety—Doxorubicin—testicular cancer	0.000159	0.000613	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—testicular cancer	0.000159	0.000612	CcSEcCtD
Cefaclor—Discomfort—Doxorubicin—testicular cancer	0.000158	0.000608	CcSEcCtD
Cefaclor—Anorexia—Epirubicin—testicular cancer	0.000158	0.000608	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—testicular cancer	0.000158	0.000607	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—testicular cancer	0.000157	0.000605	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—testicular cancer	0.000156	0.0006	CcSEcCtD
Cefaclor—Hypotension—Epirubicin—testicular cancer	0.000154	0.000596	CcSEcCtD
Cefaclor—Confusional state—Doxorubicin—testicular cancer	0.000154	0.000595	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—testicular cancer	0.000154	0.000592	CcSEcCtD
Cefaclor—Anaphylactic shock—Doxorubicin—testicular cancer	0.000153	0.00059	CcSEcCtD
Cefaclor—Oedema—Doxorubicin—testicular cancer	0.000153	0.00059	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000153	0.000588	CcSEcCtD
Cefaclor—Pain—Methotrexate—testicular cancer	0.000151	0.000582	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000151	0.000581	CcSEcCtD
Cefaclor—Shock—Doxorubicin—testicular cancer	0.000151	0.00058	CcSEcCtD
Cefaclor—Nervous system disorder—Doxorubicin—testicular cancer	0.00015	0.000578	CcSEcCtD
Cefaclor—Thrombocytopenia—Doxorubicin—testicular cancer	0.00015	0.000577	CcSEcCtD
Cefaclor—Insomnia—Epirubicin—testicular cancer	0.00015	0.000576	CcSEcCtD
Cefaclor—Paraesthesia—Epirubicin—testicular cancer	0.000148	0.000572	CcSEcCtD
Cefaclor—Hyperhidrosis—Doxorubicin—testicular cancer	0.000148	0.00057	CcSEcCtD
Cefaclor—Dyspnoea—Epirubicin—testicular cancer	0.000147	0.000568	CcSEcCtD
Cefaclor—Somnolence—Epirubicin—testicular cancer	0.000147	0.000567	CcSEcCtD
Cefaclor—Anorexia—Doxorubicin—testicular cancer	0.000146	0.000562	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—testicular cancer	0.000146	0.000561	CcSEcCtD
Cefaclor—Dyspepsia—Epirubicin—testicular cancer	0.000146	0.000561	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—testicular cancer	0.000144	0.000557	CcSEcCtD
Cefaclor—Decreased appetite—Epirubicin—testicular cancer	0.000144	0.000554	CcSEcCtD
Cefaclor—Hypotension—Doxorubicin—testicular cancer	0.000143	0.000551	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000143	0.00055	CcSEcCtD
Cefaclor—Pain—Epirubicin—testicular cancer	0.000141	0.000545	CcSEcCtD
Cefaclor—Constipation—Epirubicin—testicular cancer	0.000141	0.000545	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—testicular cancer	0.00014	0.000541	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—testicular cancer	0.00014	0.000538	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—testicular cancer	0.00014	0.000538	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000139	0.000537	CcSEcCtD
Cefaclor—Insomnia—Doxorubicin—testicular cancer	0.000138	0.000533	CcSEcCtD
Cefaclor—Paraesthesia—Doxorubicin—testicular cancer	0.000137	0.00053	CcSEcCtD
Cefaclor—Dyspnoea—Doxorubicin—testicular cancer	0.000136	0.000526	CcSEcCtD
Cefaclor—Feeling abnormal—Epirubicin—testicular cancer	0.000136	0.000525	CcSEcCtD
Cefaclor—Somnolence—Doxorubicin—testicular cancer	0.000136	0.000524	CcSEcCtD
Cefaclor—Gastrointestinal pain—Epirubicin—testicular cancer	0.000135	0.000521	CcSEcCtD
Cefaclor—Dyspepsia—Doxorubicin—testicular cancer	0.000135	0.000519	CcSEcCtD
Cefaclor—Decreased appetite—Doxorubicin—testicular cancer	0.000133	0.000513	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000132	0.000509	CcSEcCtD
Cefaclor—Urticaria—Epirubicin—testicular cancer	0.000131	0.000506	CcSEcCtD
Cefaclor—Pain—Doxorubicin—testicular cancer	0.000131	0.000504	CcSEcCtD
Cefaclor—Constipation—Doxorubicin—testicular cancer	0.000131	0.000504	CcSEcCtD
Cefaclor—Abdominal pain—Epirubicin—testicular cancer	0.000131	0.000504	CcSEcCtD
Cefaclor—Body temperature increased—Epirubicin—testicular cancer	0.000131	0.000504	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—testicular cancer	0.00013	0.000502	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—testicular cancer	0.000127	0.000489	CcSEcCtD
Cefaclor—Feeling abnormal—Doxorubicin—testicular cancer	0.000126	0.000486	CcSEcCtD
Cefaclor—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000125	0.000482	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—testicular cancer	0.000125	0.000482	CcSEcCtD
Cefaclor—Hypersensitivity—Epirubicin—testicular cancer	0.000122	0.00047	CcSEcCtD
Cefaclor—Urticaria—Doxorubicin—testicular cancer	0.000122	0.000469	CcSEcCtD
Cefaclor—Body temperature increased—Doxorubicin—testicular cancer	0.000121	0.000466	CcSEcCtD
Cefaclor—Abdominal pain—Doxorubicin—testicular cancer	0.000121	0.000466	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—testicular cancer	0.000121	0.000466	CcSEcCtD
Cefaclor—Asthenia—Epirubicin—testicular cancer	0.000119	0.000457	CcSEcCtD
Cefaclor—Pruritus—Epirubicin—testicular cancer	0.000117	0.000451	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—testicular cancer	0.000117	0.00045	CcSEcCtD
Cefaclor—Diarrhoea—Epirubicin—testicular cancer	0.000113	0.000436	CcSEcCtD
Cefaclor—Hypersensitivity—Doxorubicin—testicular cancer	0.000113	0.000434	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—testicular cancer	0.000112	0.000433	CcSEcCtD
Cefaclor—Rash—Methotrexate—testicular cancer	0.000111	0.000429	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—testicular cancer	0.000111	0.000429	CcSEcCtD
Cefaclor—Headache—Methotrexate—testicular cancer	0.000111	0.000427	CcSEcCtD
Cefaclor—Asthenia—Doxorubicin—testicular cancer	0.00011	0.000423	CcSEcCtD
Cefaclor—Dizziness—Epirubicin—testicular cancer	0.000109	0.000421	CcSEcCtD
Cefaclor—Pruritus—Doxorubicin—testicular cancer	0.000108	0.000417	CcSEcCtD
Cefaclor—Vomiting—Epirubicin—testicular cancer	0.000105	0.000405	CcSEcCtD
Cefaclor—Nausea—Methotrexate—testicular cancer	0.000105	0.000405	CcSEcCtD
Cefaclor—Diarrhoea—Doxorubicin—testicular cancer	0.000105	0.000404	CcSEcCtD
Cefaclor—Rash—Epirubicin—testicular cancer	0.000104	0.000402	CcSEcCtD
Cefaclor—Dermatitis—Epirubicin—testicular cancer	0.000104	0.000401	CcSEcCtD
Cefaclor—Headache—Epirubicin—testicular cancer	0.000104	0.000399	CcSEcCtD
Cefaclor—Dizziness—Doxorubicin—testicular cancer	0.000101	0.00039	CcSEcCtD
Cefaclor—Nausea—Epirubicin—testicular cancer	9.82e-05	0.000379	CcSEcCtD
Cefaclor—Vomiting—Doxorubicin—testicular cancer	9.73e-05	0.000375	CcSEcCtD
Cefaclor—Rash—Doxorubicin—testicular cancer	9.65e-05	0.000372	CcSEcCtD
Cefaclor—Dermatitis—Doxorubicin—testicular cancer	9.64e-05	0.000371	CcSEcCtD
Cefaclor—Headache—Doxorubicin—testicular cancer	9.58e-05	0.000369	CcSEcCtD
Cefaclor—Nausea—Doxorubicin—testicular cancer	9.09e-05	0.00035	CcSEcCtD
